Skip to main content
Download PDF
- Main
In Reply
Published Web Location
https://doi.org/10.1002/onco.13782Abstract
This letter to the editor responds to Badoui et al. regarding data on abemaciclib dosages and adverse events.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.